Pulsenmore, a home ultrasound company, raised $40 million in its iàs TASE IPO at a $190 million valuation of the company, before getting the money. All of the money raised by the company, which has seen demand buoyed by the telemedicine boom in the wake of the Covid pandemic, will go to the company, with none of the bidding offered by existing shareholders. Related to Major Ultrasound Related Materials Pulsenmore Files for TASE IPO As far as is known, investors included a group of leading Israeli institutional investors including three large insurance companies, two large savings funds and one major hedge fund. Shareholders include Fujifilm, the leading ultrasound manufacturer, and industry-leading physicians. The company, which was founded by Dr. Elazar Sonnenchin in 2015, has no income, but an agreement with Clalit Health Fund enabled it to report an order backlog of NIS 2.5 million last week for delivery in the first half of this year, and NIS 15.7 million backlog for delivery in the second half. of the year. At present the company has no other clients. Sonnenschein previously founded Medigus, which developed an endoscope for the non-invasive treatment of gastroesophageal reflux disease (GERD). In its last funding round in March 2020, which was completed before the Covid-19 pandemic spread, the company raised $30 million. Pulsenmore is for home use by pregnant women. It is intended to reduce the need to visit emergency departments in the hospital when the feeling of fetal movements stops or when there is another reason to fear for the condition of the fetus. The patient receives instructions via her mobile phone on how to scan the abdominal area and sends the examination to the doctor who interprets it immediately. There is a limit to the number of examinations that can be performed in one day or throughout the pregnancy, so as not to confuse the doctors. Published by Globes, Israel business news – en.globes.co.il – June 10, 2021 © Copyright Globes Publisher Itonut (1983) Ltd. 2021
Major ultrasound company Pulsenmore raises $40 million in TASE IPO
0 Comments